超声弹性成像应变率比值在子宫肌瘤聚桂醇硬化治疗疗效评价中的应用

发布时间：2018-05-19 01:20

本文选题：超声弹性成像 + 应变率比值　；参考：《山东医药》2016年07期

【摘要】：目的探讨超声弹性成像应变率比值(SR)在子宫肌瘤聚桂醇硬化治疗疗效评价中的应用价值。方法接受超声引导下聚桂醇硬化治疗的子宫肌瘤患者40例(共43枚肌瘤),分别于治疗前及治疗后1、6个月进行超声弹性成像检查,计算病灶SR。依据治疗后6个月超声造影检查结果,将43个瘤体分为完全灭活组及部分灭活组,比较两组治疗前后SR。结果 43个瘤体中,完全灭活组24个瘤体,部分灭活组19个瘤体。完全灭活组治疗前及治疗1、6个月病灶SR分别为2.61±1.48、2.57±1.79、3.32±1.62,部分灭活组分别为1.30±0.57、1.25±0.60、1.82±0.65;两组各时点SR相比,P均0.05;同组治疗后6个月与治疗前相比,P均0.01。术后1个月SR诊断临界值为1.69时,判断瘤体完全灭活的敏感性、特异性、准确性分别为81%、89.5%、85.5%;术后6个月SR诊断临界值为2.085时,判断瘤体完全灭活的敏感性、特异性、准确性分别为100%、84.2%、92.5%。结论超声弹性成像SR能较为客观地反映病灶硬度,在子宫肌瘤聚桂醇硬化治疗疗效评价中应用效能较好。
[Abstract]:Objective to evaluate the value of strain rate ratio (SRR) of ultrasonic elastic imaging in the treatment of uterine leiomyoma with polycinnamol. Methods 40 patients (43 leiomyomas) with hysteromyoma treated with polycinnamol sclerosis under ultrasound guidance were examined by elastography before treatment and 1 and 6 months after treatment. SRS were calculated. According to the results of contrast-enhanced ultrasonography 6 months after treatment, 43 tumors were divided into two groups: completely inactivated group and partially inactivated group. The SRS before and after treatment were compared between the two groups. Results among 43 tumors, 24 were completely inactivated and 19 were partially inactivated. The SR of the lesions in the completely inactivated group was 2.61 卤1.48t 2.57 卤1.79 卤3.32 卤1.62before treatment and 1.30 卤0.571.25 卤0.601.82 卤0.65 in the partially inactivated group, respectively. When the critical value of SR diagnosis was 1.69, the sensitivity, specificity and accuracy of the complete inactivation of the tumor were 81- 89.5 and 2.085, respectively, and the sensitivity and specificity of the total inactivation of the tumor were determined by the SR diagnostic threshold of 2.085 at 6 months after the operation. The accuracy is 100, 84.2 and 92.5, respectively. Conclusion Ultrasound elastography SR can objectively reflect the hardness of the lesion and is effective in evaluating the curative effect of polycinnamol in the treatment of uterine leiomyoma.
【作者单位】：南通大学附属医院;
【基金】：南通市社会发展基金项目(BK2011074)
【分类号】：R445.1;R737.33

【相似文献】